Individual tests

AFP is a type of tumor marker produced by cancer cells or normal cells in response to cancer. High levels of AFP can indicate cancer of the liver, ovaries, or testicles. However, other non-cancerous conditions can also increase AFP levels, so this test alone can't fully diagnose cancer.
This test helps monitor certain cancers during and after treatment and checks for recurrence. It can identify early signs of ovarian cancer in high-risk patients. Some non-cancerous conditions can increase the level of this protein, such as menstruation and uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal, and fallopian tube cancers.
If your CA 15-3 results are elevated, additional testing is needed to diagnose breast cancer. If the elevation is minimal, you may need to watch, wait, and order a repeat test 4-6 weeks later. The CA 15-3 elevations in non-cancerous conditions tend to be stable over time. If elevation persists or increases, you may need additional testing, such as breast ultrasound, mammography, or a CT scan
The CA 19.9 quantitative test screens for abnormalities related to the pancreas and bile.
Cancer antigen CA72-4 is a tumor marker found elevated in various human malignant tumors, including ovarian, gastrointestinal (i.e., stomach, colon, and small bowel), and pancreatic cancer. It is used to manage metastatic and recurrent cancer and assess antitumor therapy response.
Carcinoembryonic antigen (CEA) is a protein of the developing fetus. CEA levels gradually decrease or disappear after birth. In adults, abnormal CEA levels can indicate cancer. Smoking can also increase CEA. The test helps monitor treatment and checks for the recurrence of cancers of the colon, thyroid gland, rectum, lung, breast, liver, pancreas, stomach, and ovaries.
Creatine kinase (CK) is an enzyme that occurs naturally in your muscle cells, while CK-MB mainly occurs in your heart's muscle cells. Damage to heart muscle cells causes CK-MB to leak into your blood. This test helps detect how much CK-MB enzyme is in your blood. If there’s more CK-MB in your blood than there should be, it can be a sign you’ve had a heart attack.
Creatine Kinase is an enzyme found in heart, brain, and skeletal muscle. This test detects muscle inflammation or damage due to muscle disorders.
Creatinine is a waste product your muscles produce as part of regular, everyday activities. Normally, your kidneys filter creatinine from your blood and send it out of the body in your urine. If there is a kidney problem, creatinine can build up in the blood, and less will be released in urine.
Creatinine is a waste product your muscles produce as part of everyday activities. Normally, your kidneys filter creatinine from your blood and send it out of the body in your urine. If there is a kidney problem, creatinine can build up in the blood, and less will be released in urine.
CYFRA 21-1 is useful as a tumor marker, especially for non-small cell lung cancer (NSCLC), CEA, SCC, and other epithelial tumors such as in bladder cancer. This elevation in tumors may be due to cell lysis releasing cell contents into the blood.
D-dimer is a protein fragment produced when a blood clot dissolves in your body. Blood clots prevent you from losing too much blood when injured. Normally, your body will dissolve the clot once your injury heals. With a clotting disorder, clots form when you aren't injured or don't dissolve when they should. These conditions are serious and potentially life-threatening. A D-dimer test can show if you have one of these conditions.
Creatinine is a waste byproduct of normal muscle activity. The kidneys remove creatinine from the blood and it is then excreted through urine. A creatinine clearance test assesses how well the kidneys filter blood and is important for detecting and monitoring kidney problems.
loading.svg